Klotho Neurosciences, Inc. (KLTO)
0.2402
+0.02
(+8.84%)
USD |
NASDAQ |
Feb 06, 16:00
0.2345
-0.01
(-2.37%)
After-Hours: 20:00
Klotho Neurosciences Shareholders Equity (Quarterly) : 9.927M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Agenus, Inc. | -274.14M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Savara, Inc. | 94.39M |
| Arrowhead Pharmaceuticals, Inc. | 568.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.07M |
| Total Liabilities (Quarterly) | 0.1459M |
| Current Ratio | 83.68 |
| Net Debt Paydown Yield | 2.31% |